Current advances in clinical pathophysiology in the study of the pathogenesis of type 1 and type 2 diabetes mellitus in humans
DOI:
https://doi.org/10.22141/2224-0721.15.6.2019.185403Keywords:
clinical pathophysiology, diabetes mellitus type 1 and 2 in a human, diagnosis, pathogenesis, reviewAbstract
The review deals with the development and achievements in a new scientific direction in medicine studying the pathogenesis of various human diseases — clinical pathophysiology over the last decades. The latest low-traumatic intravital highly sensitive research methods used in pathophysiology for studying the important vital physiological and immunological processes in an organism of patients with type 1 and type 2 diabetes mellitus made it possible to show that the etiopathogenesis of these diseases in humans significantly differs from that in animals with experimental diabetes mellitus. This made it possible to obtain more accurate information about the causes and natural course of diabetes mellitus in humans that requires the development of new methods for its diagnosis, especially at the preclinical stage of development and to stimulate the development of more effective agents for the prevention and treatment of this disease.References
Zak KP, Tron'ko ND, Popova VV, Butenko AK. Sakharnyi diabet. Immunitet. Tsitokiny [Diabetes. Immunity. Cytokines]. Kyiv: Knyga-pljus; 2015. 485 p. (in Russian).
Tron’ko ND, Popova VV, Zak KP, Mankovsky BN. About the scientific research prospective program on Immunity in the preclinical period of the development of type 1 diabetes created at the State Institution VP Komisarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Sciences of Ukraine. Endokrynologia. 2010;15(2):180-191. (in Russian).
Zak KP, Afanasyeva VV, Khruzov MA. Quantity and ultrastructure of lymphocytes of different immunophenotype in blood of elderly patients with type 2 diabetes with different body weight. In: Proceeding of the II International Conference on Microcirculation and Its Age-Related Changes. 2002, May 22-24; Kyiv, Ukraine. Kyiv; 2002. 118-119 pp. (in Ukrainian).
Afanasyeva VV, Zak KP, Efimov AS. Blood monocytes in type 1 diabetes: electron-microscopic and ultra-cytochemical studies. Terapevticheskiy arkhiv. 1988;60(5):95-98. (in Russian).
Khomenko BM, Gruzov MA, Shliakhovenko VS, Zak KP. The content and ultrastructure of blood CD4+ lymphocytes in healthy people and patients with type 1 diabetes. Fiziologichnyi Zhurnal. 1989;35(5):31-38. (in Russian).
Zak KP, Popova VV, Melnychenko SV, Mankovsky BN. The level of circulating cytokines and chemokines in the preclinical and early clinical stages of the development of type 1 diabetes. Terapevticheskiy arkhiv. 2010;82(10):147-153. (in Russian).
Afanasyeva VV, Zak KP, Kondratska IM, Semionova TA. Content, ultrastructure and function of blood monocytes in patients with type 2 diabetes and metabolic syndrome. Endokrynologia. 2009;14(2):201-218. (in Ukrainian).
Tron’ko ND, Zak KP. Obesity and diabetes. Lik Sprava. 2013 Dec;(8):3-21. (in Russian).
Zak KP, Kondratska IN, Melnychenko SV, Popova VV. The level of circulating IL-16 in the blood of patients with metabolic syndrome and type 2 diabetes. Lik sprava. 2007;(5-6):46-9. (in Russian).
Kondratska IN, Zak KP, Mankovsky BN. The level of circulating leptin in the blood in patients with metabolic syndrome and type 2 diabetes. Ukrainian Journal of Cardiology. 2009;(2):30-33. (in Russian).
Downloads
Issue
Section
License
Copyright (c) 2020 M.D. Tronko, K.P. Zak

This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.